Member

Claryx


Claryx is building the hospital immune system, reading the genomes of confirmed patient infections, linking related cases as outbreaks, and tracing each back to its likely source. When that source is in the building (a sink, a shared piece of equipment, a particular room), Claryx finds it by matching the patient's strain against a digital twin of the hospital's microbiome, sequenced from its air, its water and its surfaces, all on proprietary chemistry cheap enough to run continuously. Claryx is based in New York and live across multiple health systems.

Industries

N/A

Nr. of Employees

small (1-50)

Claryx is currently seeking investment

Claryx is seeking a seed investment in the range of 5m-20m

All Investment-seeking Members

Expertise Areas

  • Infectious disease surveillance
  • Environmental pathogen monitoring
  • Genomic data analysis
  • Antimicrobial resistance research

Key Technologies

  • Genomic sequencing
  • Environmental DNA (eDNA) analysis
  • Bioinformatics
  • Genome mining

Key People

Chief Science Officer

Chief Executive Officer


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.